EMBL scientists discover that an FDA-approved, over-the-counter cough syrup ingredient has potential to treat fibrotic lung ...

The 'Father of the Bride' actress lost her ability to speak for two years before undergoing a laryngoplasty to fix her vocal ...

Excessive drinking can damage the liver. Yet, unlike obesity or high cholesterol, clinicians only screen for alcohol use by ...

Syntara Limited (ASX:SNT), a clinical-stage drug development company, is pleased to announce positive interim data from its ongoing Phase 2 clinical trial evaluating SNT-5505 (200 mg BID) in ...

We hope that these early findings can usher in new treatment options for PVR and other eye diseases.” PVR is scar tissue that forms inside the eye ... please contact the cited source. Our press ...

WHISTLE-PF will test the efficacy of various daily oral doses of ENV-101 against a placebo in adults with idiopathic ...

Refoxy Pharmaceuticals GmbH is a preclinical biotech company developing small molecule activators of the FOXO3 transcription factor for the treatment of age-related diseases. Today, the company ...

A Phase 2b clinical trial testing Haduvio for IPF cough reached 75% of targeted enrollment but is still recruiting patients ...

The positive opinion could lead to the first approval of a therapy for these conditions in children ... Ofev works by ...

Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn’s diseasePrimary endpoints met in ...

If physical therapy is advised ... Manual techniques like myofascial release can aid with healing and help reduce the amount of scar tissue that develops. The excessive buildup of scar tissue can lead ...